Page last updated: 2024-09-04

varespladib and Aortic Diseases

varespladib has been researched along with Aortic Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Behrendt, M; Dikkers, A; Gautier, T; Grass, DS; Hurt-Camejo, E; Rader, DJ; Rosengren, B; Tietge, UJ	1

Other Studies

1 other study(ies) available for varespladib and Aortic Diseases

Article	Year
Expression of type IIA secretory phospholipase A2 inhibits cholesteryl ester transfer protein activity in transgenic mice. Arteriosclerosis, thrombosis, and vascular biology, 2013, Volume: 33, Issue:12 Topics: Acetates; Animals; Aorta; Aortic Diseases; Apolipoprotein E3; Apolipoproteins B; Atherosclerosis; Cholesterol Ester Transfer Proteins; Disease Models, Animal; Enzyme Inhibitors; Female; Group II Phospholipases A2; Humans; Hypercholesterolemia; Indoles; Keto Acids; Lipoproteins, VLDL; Liver; Mice; Mice, Inbred C57BL; Mice, Transgenic; Plaque, Atherosclerotic	2013

Article

Year

Expression of type IIA secretory phospholipase A2 inhibits cholesteryl ester transfer protein activity in transgenic mice.

Arteriosclerosis, thrombosis, and vascular biology, 2013, Volume: 33, Issue:12

Topics: Acetates; Animals; Aorta; Aortic Diseases; Apolipoprotein E3; Apolipoproteins B; Atherosclerosis; Cholesterol Ester Transfer Proteins; Disease Models, Animal; Enzyme Inhibitors; Female; Group II Phospholipases A2; Humans; Hypercholesterolemia; Indoles; Keto Acids; Lipoproteins, VLDL; Liver; Mice; Mice, Inbred C57BL; Mice, Transgenic; Plaque, Atherosclerotic

2013